MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ahj.2013.03.007

Медицинская библиотека · American heart journal · 2013

Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure.

Curtis Lesley H, Mi Xiaojuan, Qualls Laura G, Check Devon K, Hammill Bradley G, Hammill Stephen C, Heidenreich Paul A, Masoudi Frederick A, Setoguchi Soko, Hernandez Adrian F, Fonarow Gregg C

Сравнительное исследованиеСтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

Aldosterone antagonist therapy is recommended for selected patients with heart failure and reduced ejection fraction. Adherence to therapy in the transition from hospital to home is not well understood.

METHODS

We identified patients with heart failure and reduced ejection fraction who were ≥65 years old, eligible for aldosterone antagonist therapy, and discharged home from hospitals in the Get With the Guidelines-Heart Failure registry between January 1, 2005, and December 31, 2008. We used Medicare prescription drug event data to measure adherence. Main outcome measures were prescription at discharge, outpatient prescription claim within 90 days, discontinuation, and adherence as measured with the medication possession ratio. We used the cumulative incidence function to estimate rates of initiation and discontinuation.

RESULTS

Among 2,086 eligible patients, 561 (26.9%) were prescribed an aldosterone antagonist at discharge. Within 90 days, 78.6% of eligible patients with a discharge prescription filled a prescription for the therapy, compared with 13.0% of eligible patients without a discharge prescription (P < .001). The median medication possession ratio was 0.63 over 1 year of follow-up. Among 634 patients who filled a prescription within 90 days of discharge, 7.9% discontinued therapy within 1 year.

CONCLUSION

Most eligible patients were not prescribed aldosterone antagonist therapy at discharge from a heart failure hospitalization. Eligible patients without a discharge prescription seldom initiated therapy as outpatients. Most patients who were prescribed an aldosterone antagonist at discharge filled the prescription within 90 days and remained on therapy.

Для цитирования: Curtis Lesley H, Mi Xiaojuan, Qualls Laura G, Check Devon K, Hammill Bradley G, Hammill Stephen C, Heidenreich Paul A, Masoudi Frederick A, Setoguchi Soko, Hernandez Adrian F, Fonarow Gregg C. Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure.. American heart journal. 2013. DOI: 10.1016/j.ahj.2013.03.007.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.